Eris Lifesciences Limited

BSE:540596 Stock Report

Market Cap: ₹174.7b

Eris Lifesciences Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Amit Bakshi

Chief executive officer

₹48.8m

Total compensation

CEO salary percentage35.9%
CEO tenure18.1yrs
CEO ownership42.9%
Management average tenure8.4yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Amit Bakshi's remuneration changed compared to Eris Lifesciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

₹3b

Sep 30 2024n/an/a

₹3b

Jun 30 2024n/an/a

₹4b

Mar 31 2024₹49m₹17m

₹4b

Dec 31 2023n/an/a

₹4b

Sep 30 2023n/an/a

₹4b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹49m₹17m

₹4b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹4b

Jun 30 2022n/an/a

₹4b

Mar 31 2022₹46m₹26m

₹4b

Dec 31 2021n/an/a

₹4b

Sep 30 2021n/an/a

₹4b

Jun 30 2021n/an/a

₹4b

Mar 31 2021₹27m₹27m

₹4b

Dec 31 2020n/an/a

₹3b

Sep 30 2020n/an/a

₹3b

Jun 30 2020n/an/a

₹3b

Mar 31 2020₹49m₹18m

₹3b

Dec 31 2019n/an/a

₹3b

Sep 30 2019n/an/a

₹3b

Jun 30 2019n/an/a

₹3b

Mar 31 2019₹49m₹18m

₹3b

Dec 31 2018n/an/a

₹3b

Sep 30 2018n/an/a

₹3b

Jun 30 2018n/an/a

₹3b

Mar 31 2018₹49m₹11m

₹3b

Compensation vs Market: Amit's total compensation ($USD561.52K) is about average for companies of similar size in the Indian market ($USD489.84K).

Compensation vs Earnings: Amit's compensation has been consistent with company performance over the past year.

CEO

Amit Bakshi (49 yo)

18.1yrs

Tenure

₹48,776,648

Compensation

Mr. Amit Indubhushan Bakshi serves as Chairman and Managing Director at Eris Lifesciences Limited. Mr. Bakshi has an extensive experience of Indian Pharmaceutical industry and handles Strategic Management...

Leadership Team

NamePositionTenureCompensationOwnership
Amit Bakshi
Chairman & MDno data₹48.78m42.85%
₹ 74.9b
Sachin Shah
Chief Financial Officer8.4yrs₹18.01mno data
Krishnakumar Vaidyanathan
Executive Director & COO3.8yrs₹44.85mno data
Gagan Atreja
President of Sales & Marketingno data₹22.05mno data
Inderjeet Negi
Executive Directorno data₹12.40m4.36%
₹ 7.6b
Kaushal Shah
Whole Time Directorno data₹6.99m3.28%
₹ 5.7b
Deepak Kapoor
Senior Vice Presidentno data₹13.72mno data
Milind Talegaonkar
Compliance Officer & Company Secretary8.4yrsno datano data
Vijay Joshi
President Medicalno data₹12.31mno data
Manish Kapoor
Vice Presidentno data₹12.36mno data
Alok Mahajan
Vice Presidentno data₹13.30mno data
Viraj Suvarna
Vice Presidentno data₹15.08mno data

8.4yrs

Average Tenure

50yo

Average Age

Experienced Management: 540596's management team is seasoned and experienced (8.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Amit Bakshi
Chairman & MD18.1yrs₹48.78m42.85%
₹ 74.9b
Krishnakumar Vaidyanathan
Executive Director & COO4.2yrs₹44.85mno data
Inderjeet Negi
Executive Director18.1yrs₹12.40m4.36%
₹ 7.6b
Kaushal Shah
Whole Time Director4.5yrs₹6.99m3.28%
₹ 5.7b
Prashant Gupta
Independent Non-Executive Director6.8yrs₹4.13mno data
Sujesh Vasudevan
Independent Non-Executive Director2.6yrs₹4.05mno data
Kalpana Unadkat
Independent Non-Executive Director4.1yrs₹4.51mno data
Rajeev Dalal
Independent Non-Executive Director4.2yrs₹4.65mno data

4.3yrs

Average Tenure

50yo

Average Age

Experienced Board: 540596's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/19 20:20
End of Day Share Price 2025/02/19 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Eris Lifesciences Limited is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
Nitin BhasinAmbit Capital
Harith AhamedAvendus Spark